Valuing Unlisted Equity Instruments for IFRS 2 Share-Based Payments

IFRS 2 Share-Based Payment requires entities to measure equity instruments granted at their fair value. For listed shares, this is simple. However, determining the fair value of unquoted instruments for private companies presents a significant challenge due to the absence of an observable market. Expert valuation is thus critical for accurate reporting and compliance.

The Core Principle of Fair Value Measurement

IFRS 13 defines fair value as the price in an orderly transaction between market participants. For unquoted equity, this means estimating a hypothetical price a knowledgeable buyer and seller would agree upon. This estimation relies heavily on appropriate methodologies and professional judgment, reflecting the instrument's economic reality.

Key Valuation Approaches

Actuaries and valuers typically employ one or a combination of three widely accepted approaches to determine unquoted equity fair value:

**1. Market Approach:** This method compares the target company to similar businesses with available market data, using multiples (e.g., Enterprise Value/EBITDA) from public comparables or private transactions. Significant adjustments are essential for differences in size, growth, liquidity, and control between the subject company and its peers.

**2. Income Approach:** The Discounted Cash Flow (DCF) method is most common. It projects future free cash flows and discounts them to present value using an appropriate rate (WACC). Its reliability depends on accurate projections and a defensible discount rate, making sensitivity analysis on key inputs vital.

**3. Asset-Based Approach:** Less common for operating companies, this approach values a company by summing the fair value of its underlying assets and liabilities. It's often applicable for asset-heavy businesses or early-stage ventures where asset value is primary.

Critical Inputs and Considerations

Beyond the chosen approach, several specific factors demand careful consideration:

**Complex Capital Structures:** Private companies often have multiple share classes with varying rights and liquidation priorities. Methods like the Probability-Weighted Expected Return Method (PWERM) or option pricing models are used to allocate overall equity value among these classes.

**Discount for Lack of Marketability (DLOM):** Unquoted shares lack the liquidity of public shares. A DLOM is typically applied to reflect this inability to readily convert the investment into cash, significantly impacting fair value. Robust support for this discount is essential.

**Company-Specific Factors:** Company stage, financial performance, industry outlook, competitive landscape, management quality, and economic conditions all play a vital role in shaping valuation inputs and assumptions.

The Indispensable Role of Expert Judgment

Valuing unquoted equity instruments is not a mechanical exercise. It requires significant professional judgment, deep understanding of valuation principles, and experience in diverse business scenarios. Actuaries and valuation specialists bring this expertise, ensuring methodologies, inputs, and assumptions are appropriate and IFRS compliant.

In conclusion, determining the fair value of unquoted equity for IFRS 2 share-based payments is complex but essential. A robust, well-documented valuation, grounded in appropriate methodologies and expert judgment, is crucial for accurate financial reporting and stakeholder confidence. Engaging experienced valuation professionals is key to success.